Skip to content

Fluoroscopy Versus Ultrasound Guidance for Sacral Lateral Branch Radiofrequency Ablation

A Prospective Randomized Comparison of Fluoroscopy and Ultrasound Guidance for Sacral Lateral Branch Radiofrequency Ablation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05520463
Enrollment
60
Registered
2022-08-30
Start date
2022-09-01
Completion date
2023-07-05
Last updated
2023-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Back Pain, Sacroiliac Joint Arthritis

Brief summary

Sacroiliac joint is a diarthroidal and synovial joint that receives sensory innervatin by the sacral lateral branches ( commonly S1-3, with variable contributions from L5 dorsal ramus and S4 lateral branch). Sacral lateral branch radiofrequency ablation and block techniques are widely used for the management of sacroiliac joint pain. With the increasing use of ultrasound technology in pain medicine, the ultrasound guided approaches gained popularity. To our knowledge, there are no randomized controlled trials comparing the ultrasound and fluoroscopy approaches for sacral lateral branch radiofrequency ablation. This study aims to compare the ultrasound and fluoroscopy guidance techniques for sacral lateral branch radiofrequency ablation.

Interventions

PROCEDURESacral lateral branch radiofrequency ablation under ultrasound guidance

Sacral lateral branch radiofrequency ablation will be performed under ultrasound guided approach.

PROCEDURESacral lateral branch radiofrequency ablation under fluoroscopy guidance

Sacral lateral branch radiofrequency ablation will be performed under fluoroscopy guided approach.

Sponsors

Diskapi Teaching and Research Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Low back pain due to sacroiliac joint dysfunction \>6 months with a score ≥ 4 on a numeric rating scale. * 50% pain relief after prognostic sacral lateral branch block * At least 3 positive physical examination maneuvers \[ Faber ( flexioni abduction and external rotation), POSH (posteripr shear), REAB ( resisted abduction), Gaenslen's test, Distraction test\] * Refractory to conservative therapy

Exclusion criteria

The

Design outcomes

Primary

MeasureTime frameDescription
Change in pain numerical rating score from baseline3 monthsThe numerical rating score (NRS) will be used to assess the severity of pain felt by a patient. . The patient rates pain on a scale of 0 to 10; 0 represents 'no pain' and 10 ,represents 'worst pain imaginable'

Secondary

MeasureTime frameDescription
Pain medication useAt 3 monthsMean change in analgesic consumption is assessed using QAQ, a tool designed to record patient-reported pain medication use. The higher score indicates higher pain medication use
Success rateAt 3 monthsProportions of reporting \>50% pain relief.
Functional disabilityAt 1 and 3 monthsChange in Oswestry Disabilit Index ( Scale 0-100). 0 point is equated with no disability and 100 point is maximum disability possible
Patient satisfactionAt 3 monthsChanges in overall satisfaction will be assessed using a 5-point Likert scale. (1, very dissatisfied; 2, dissatisfied; 3, neutral; 4, satisfied; 5, very satisfied).
The number of needle passessDuring the procedureThe number of attempts during the performance will be analysed.
Performance timeDuring the procedureRadiofrequency ablation performance time will be recorded from the time the first image is obtained, until the procedure is completed
Quality of life ( SF-36)At 1 and 3 monthsQuality of life (QoL) will assessed via SF-36, which consists of 36 items ad 2 summary values for Physical Component Summary ( PSC) and Mental Component Summary (MSC). Subscale scores range from 0 to 100, with 100 being the most positive QoL in that area and 0 the lowest;

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026